Million Health Pharamceuticals

Drug profile : Myhep dvir   tablet, a combination of two most effective anti-viral agents called as Sofosbuvir & Daclatasvir. This tablet is most effective against serious condition like hepatitis C viral infection induced by genotype I or III. Myhep dvir  tablet is the merger of two non structural proteins like NS5A & NS5B inhibitors. This phosphoprotein is important for viral production. Myhep dvir  tablets are used as single dose therapy, which is most efficient for treating the hepatitis condition. MYHEP-DVIR Prescribing information : Myhep dvir  tablets are utilized to treat the propelled hepatitis C viral diseases related with genotypes I or III. For the most part Daclatasvir is utilized as a part of mix with sofosbuvir for better against viral action. In decompensated cirrhosis condition, Myhep dvir ought to be utilized simultaneously with ribavirin Mechanism: After oral confirmation of Myhep dvir tablets, it might experience some structure for

Drug profile of Geftinat Geftinat   250mg tablets  are cipla manufactured product which is endorsed by FDA with anti-neoplastic activity. Geftinat 250mg  containing active constituent known as Gefitinib is an inhibitor of epidermal growth factor receptor. Geftinat 250mg  is only powerful in tumor cells which get mutated & uncontrolled EGFR. Geftinat 250mg   is also characterized as single transduction inhibitor by intercede with EGFR.  Geftinat 250mg Tablets  is active against tyrosine kinase protein. Chemically  Gefitinib 250mg Tablets  is categorized as anilinoquinazoline with anti-tumor activity. Geftinat 250mg   is pharmacologically classified as; Anti-neoplastic agent Epidermal growth factor signal transduction inhibitor Tyrosine kinase inhibitor GEFTINAT Brand name: Geftinat Active substance: Gefitinib Strength: 250mg Mfg: Cipla Pack: 30 tablets in a container Classified as: EFGR inhibitor, kinase inhibitor or Anti-neoplastic agent Pr